Private Advisor Group
CTOR icon

Private Advisor Group’s Citius Oncology CTOR Stock Holding History

Private Advisor Group’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.2K Buy
+25,000
New +$19.6K ﹤0.01% 3092

Other funds holding CTOR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Private Advisor Group's CTOR Position: Q3 2026 in Review

Private Advisor Group opened a new position in Citius Oncology (CTOR) in Q3 2026: 25,000 shares worth $25.2K. The stake represents ﹤0.01% of the portfolio and ranks #3092 among its holdings.

7 funds tracked by Wall St. Rank hold CTOR as of Q3 2026.

  • Private Advisor Group held 25,000 shares of Citius Oncology worth $25.2K as of Q3 2026.
  • Citius Oncology was a new Private Advisor Group position in Q3 2026.
  • Citius Oncology made up ﹤0.01% of Private Advisor Group's portfolio in Q3 2026, its #3092 holding.
  • 7 funds tracked by Wall St. Rank held Citius Oncology as of Q3 2026.

Based on Private Advisor Group's 13F filing for Q3 2026, filed 10 Nov 2026.